Myasthenia Gravis: Bridging Knowledge from Pathogenesis to Patient Care

This FREE Online Conference aims to achieve the following learning objectives: identify immunopathological hallmarks of progressive MS; quantify severity and establish prognosis based on innovative prognostic markers; describe new immunological targets of treatments considering the immune players involved in MS; detect early symptoms and signs of progression by using conventional and digital assessments; and discuss the results of clinical trials exploring the efficacy of new treatments, such as BTK inhibitors, targeting compartmentalized inflammation in MS.